Ligand-dependent interactions of the Ah receptor with coactivators in a mammalian two-hybrid assay.

[1]  Jeong Hoon Kim,et al.  Role of the N-Terminal Activation Domain of the Coiled-Coil Coactivator in Mediating Transcriptional Activation by β-Catenin , 2006 .

[2]  C. Tohyama,et al.  The 2005 World Health Organization reevaluation of human and Mammalian toxic equivalency factors for dioxins and dioxin-like compounds. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[3]  Jeong Hoon Kim,et al.  Downstream signaling mechanism of the C-terminal activation domain of transcriptional coactivator CoCoA , 2006, Nucleic acids research.

[4]  Timothy V. Beischlag,et al.  Role of GAC63 in Transcriptional Activation Mediated by the Aryl Hydrocarbon Receptor* , 2006, Journal of Biological Chemistry.

[5]  R. Roeder,et al.  Transcriptional regulation and the role of diverse coactivators in animal cells , 2005, FEBS letters.

[6]  Robert T. Taylor,et al.  Recruitment of Thyroid Hormone Receptor/Retinoblastoma-interacting Protein 230 by the Aryl Hydrocarbon Receptor Nuclear Translocator Is Required for the Transcriptional Response to Both Dioxin and Hypoxia* , 2004, Journal of Biological Chemistry.

[7]  Jeong Hoon Kim,et al.  Role of the Coiled-coil Coactivator (CoCoA) in Aryl Hydrocarbon Receptor-mediated Transcription* , 2004, Journal of Biological Chemistry.

[8]  S. O. Mueller,et al.  Phytoestrogens and Their Human Metabolites Show Distinct Agonistic and Antagonistic Properties on Estrogen Receptor α (ERα)and ERβ in Human Cells , 2004 .

[9]  Oliver Hankinson,et al.  Role of Mediator in Transcriptional Activation by the Aryl Hydrocarbon Receptor* , 2004, Journal of Biological Chemistry.

[10]  Bert W O'Malley,et al.  Coregulator function: a key to understanding tissue specificity of selective receptor modulators. , 2004, Endocrine reviews.

[11]  S. Safe,et al.  Flavonoids as aryl hydrocarbon receptor agonists/antagonists: effects of structure and cell context. , 2003, Environmental health perspectives.

[12]  M. Denison,et al.  Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. , 2003, Annual review of pharmacology and toxicology.

[13]  Myles A Brown,et al.  Agonist and Chemopreventative Ligands Induce Differential Transcriptional Cofactor Recruitment by Aryl Hydrocarbon Receptor , 2003, Molecular and Cellular Biology.

[14]  V. Jordan,et al.  Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions. , 2003, Journal of medicinal chemistry.

[15]  R. Casper,et al.  Interaction with Nedd8, a Ubiquitin-like Protein, Enhances the Transcriptional Activity of the Aryl Hydrocarbon Receptor* , 2002, The Journal of Biological Chemistry.

[16]  T. Zacharewski,et al.  Ability of structurally diverse natural products and synthetic chemicals to induce gene expression mediated by estrogen receptors from various species , 2002, The Journal of Steroid Biochemistry and Molecular Biology.

[17]  O. Hankinson,et al.  Recruitment of the NCoA/SRC-1/p160 Family of Transcriptional Coactivators by the Aryl Hydrocarbon Receptor/Aryl Hydrocarbon Receptor Nuclear Translocator Complex , 2002, Molecular and Cellular Biology.

[18]  O. Hankinson,et al.  Functional Involvement of the Brahma/SWI2-related Gene 1 Protein in Cytochrome P4501A1 Transcription Mediated by the Aryl Hydrocarbon Receptor Complex* , 2002, The Journal of Biological Chemistry.

[19]  K. Korach,et al.  Allosteric regulation of estrogen receptor structure, function, and coactivator recruitment by different estrogen response elements. , 2002, Molecular endocrinology.

[20]  D. Schrenk,et al.  Inducing effects of dioxin-like polychlorinated biphenyls on CYP1A in the human hepatoblastoma cell line HepG2, the rat hepatoma cell line H4IIE, and rat primary hepatocytes: comparison of relative potencies. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[21]  S. Safe,et al.  Tamoxifen-induced antitumorigenic/antiestrogenic action synergized by a selective aryl hydrocarbon receptor modulator. , 2001, Cancer research.

[22]  Y. Wan,et al.  Temporally distinct and ligand-specific recruitment of nuclear receptor-interacting peptides and cofactors to subnuclear domains containing the estrogen receptor. , 2000, Molecular endocrinology.

[23]  J. Sumpter,et al.  Differential Effects of Xenoestrogens on Coactivator Recruitment by Estrogen Receptor (ER) α and ERβ* , 2000, The Journal of Biological Chemistry.

[24]  H. Ashida,et al.  Flavones and flavonols at dietary levels inhibit a transformation of aryl hydrocarbon receptor induced by dioxin , 2000, FEBS letters.

[25]  C. Klinge,et al.  Estrogen receptor interaction with co-activators and co-repressors☆ , 2000, Steroids.

[26]  H. Ciolino,et al.  Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. , 1999, Molecular pharmacology.

[27]  Robert L. Tanguay,et al.  Transactivation activity of human, zebrafish, and rainbow trout aryl hydrocarbon receptors expressed in COS-7 cells: greater insight into species differences in toxic potency of polychlorinated dibenzo-p-dioxin, dibenzofuran, and biphenyl congeners. , 1999, Toxicology and applied pharmacology.

[28]  G. Perdew,et al.  Differential recruitment of coactivator RIP140 by Ah and estrogen receptors. Absence of a role for LXXLL motifs. , 1999, The Journal of biological chemistry.

[29]  S. Safe,et al.  Interactions of nuclear receptor coactivator/corepressor proteins with the aryl hydrocarbon receptor complex. , 1999, Archives of biochemistry and biophysics.

[30]  Safe,et al.  Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. , 1998, Environmental health perspectives.

[31]  F. Gonzalez,et al.  The aryl hydrocarbon receptor: studies using the AHR-null mice. , 1998, Drug metabolism and disposition: the biological fate of chemicals.

[32]  S. Safe,et al.  Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane. , 1998, Carcinogenesis.

[33]  H. Ciolino,et al.  Diosmin and diosmetin are agonists of the aryl hydrocarbon receptor that differentially affect cytochrome P450 1A1 activity. , 1998, Cancer research.

[34]  Y Fujii-Kuriyama,et al.  CBP/p300 functions as a possible transcriptional coactivator of Ah receptor nuclear translocator (Arnt). , 1997, Journal of biochemistry.

[35]  J. Whitlock,et al.  Transactivation domains facilitate promoter occupancy for the dioxin-inducible CYP1A1 gene in vivo , 1997, Molecular and cellular biology.

[36]  David Baunoch,et al.  Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT , 1997, Nature.

[37]  T. Gasiewicz,et al.  Analysis of structural requirements for Ah receptor antagonist activity: ellipticines, flavones, and related compounds. , 1996, Biochemical pharmacology.

[38]  J. Gustafsson,et al.  Trans-activation by the human aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator proteins: direct interactions with basal transcription factors. , 1996, Molecular pharmacology.

[39]  B. Katzenellenbogen,et al.  Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. , 1996, Molecular endocrinology.

[40]  Annika Hanberg,et al.  Toxic equivalency factors for dioxin-like PCBs , 1994, Environmental science and pollution research international.

[41]  J. Bartholomew,et al.  Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[42]  E. Glover,et al.  Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase. , 1976, The Journal of biological chemistry.

[43]  Jeong Hoon Kim,et al.  Role of the N-terminal activation domain of the coiled-coil coactivator in mediating transcriptional activation by beta-catenin. , 2006, Molecular endocrinology.

[44]  J. Hogenesch,et al.  The PAS superfamily: sensors of environmental and developmental signals. , 2000, Annual review of pharmacology and toxicology.

[45]  H. Bryant,et al.  Mechanism of action of estrogens and selective estrogen receptor modulators. , 2000, Vitamins and hormones.

[46]  T Nishihara,et al.  New screening methods for chemicals with hormonal activities using interaction of nuclear hormone receptor with coactivator. , 1999, Toxicology and applied pharmacology.

[47]  G. Perdew,et al.  Nuclear receptor coactivator SRC-1 interacts with the Q-rich subdomain of the AhR and modulates its transactivation potential. , 1999, Gene expression.

[48]  O. Hankinson.  The aryl hydrocarbon receptor complex. , 1995, Annual review of pharmacology and toxicology.

[49]  S. Safe,et al.  Comparative toxicology and mechanism of action of polychlorinated dibenzo-p-dioxins and dibenzofurans. , 1986, Annual review of pharmacology and toxicology.

[50]  A Poland,et al.  2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. , 1982, Annual review of pharmacology and toxicology.